skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

New product launches and label expansions will drive growth despite genericization of key brands

What’s the overall outlook for the multiple myeloma (MM) market? Positive or negative?

The answer is positive! Datamonitor Healthcare predicts that the extended indications for key MM drugs will lead to considerable uptake across the treatment algorithm, which will strongly contribute to the total sales of the overall MM market.






電話:+81 (0)3 6273 4260